DD
55
2
MCO
78
3
ROST
66
-2
NTRS
35
-14
ADSK
67
2
BK
68
-3
MU
42
7
EA
54
-3
WAT
61
-3
TROW
54
-2
EQT
47
8
BA
65
2
STI
24
-7
AVY
51
-2
TSN
32
-3
PNW
59
-4
AVB
57
2
STZ
55
-3
CHD
34
-5
CME
56
-3
DD
55
2
MCO
78
3
ROST
66
-2
NTRS
35
-14
ADSK
67
2
BK
68
-3
MU
42
7
EA
54
-3
WAT
61
-3
TROW
54
-2
EQT
47
8
BA
65
2
STI
24
-7
AVY
51
-2
TSN
32
-3
PNW
59
-4
AVB
57
2
STZ
55
-3
CHD
34
-5
CME
56
-3
Financhill
Back

Novonesis (Novozymes) B 10K Form

Buy
55

NVZMF
Novonesis (Novozymes) B

Last Price:
59.08
Seasonality Move:
3.57%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NVZMF News And Ratings

See the #1 stock for the next 7 days that we like better than NVZMF

NVZMF Financial Statistics

Sales & Book Value

Annual Sales: $2.6B
Cash Flow: $74.9M
Price / Cash Flow: 0
Annual Sales: $7.48
Price / Book: 2.34

Profitability

EPS (TTM): 1.58440
Net Income (TTM): $440.38M
Gross Margin: $1.41B
Return on Equity: 21.49%
Return on Assets: 10.72%

Novonesis (Novozymes) B Earnings Forecast

Key Novonesis (Novozymes) B Financial Ratios

  • The Gross Profit Margin over the past 22 years for NVZMF is 54.32%.
  • The Selling, General & Administrative Expenses for NVZMF have been equal to 18.57% of Gross Profit Margin.
  • The Research & Development expenses have been 11.27% of Revenue.
  • The Interest Expense is 5.72% of Operating Income.
  • The Net Earning history of NVZMF is 16.89% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 17 years.

Novonesis (Novozymes) B Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Chemicals
Sector: Materials
Current Symbol: NVZMF
Website: novozymes.com

Debt

Debt-to-Equity Ratio: 0.53
Current Ratio: 1.3
Quick Ratio: 0.76

Price-to-Earnings

Trailing P/E Ratio: 37.53
Forward P/E Ratio: 0

NVZMF Technical Analysis vs Fundamental Analysis

Buy
55
Novonesis (Novozymes) B (NVZMF) is a Buy

Is Novonesis (Novozymes) B a Buy or a Sell?